Assays of pancreatic B cell secretory products: Utility in investigative and clinical diabetology

References

• Yalow R S, Berson S A. Immunoassay of endogenous plasma insulin in man. J Clin Invest 1960; 39: 1157–75
   PubMed Web of Science ®Google Scholar
• WHO Expert Committee on Diabetes Mellitus. 1980, Second Report. WHO Techn Rep Ser no. 646
   Google Scholar
• National Diabetes Data Group. Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 1979; 28: 1039–57
   PubMed Web of Science ®Google Scholar
• Keen H, Jarrett R J, Alberti K GMM. Diabetes mellitus: a new look at diagnostic criteria. Diabetologia 1979; 16: 283–5
   PubMedGoogle Scholar
• Keen H, Tang Ng, Fui S. The definition and classification of diabetes mellitus. Clin Endocrinol Metab 1982; 11: 279–305
   PubMedGoogle Scholar
• Heding L G, Kasperska-Czyzykowa T. C-peptide and proinsulin after oral glucose. Acta Med Scand 1980; 33–6, (Suppl. 639)
   Google Scholar
• Kruse V, Heding L G, Jøgensen K H, Tronier B, Christensen M, Thim L, Frank B H, Root M A, Cohen R M, Rubenstein A H. Human proinsulin standards. Diabetologia 1984; 27: 414–5
   Google Scholar
• Gerbitz K-D. Pankreatische B-Zellen-Peptide: Kinetik und Konzentration von Proinsulin, Insulin und C-Peptid in Plasma und Urin, Probleme der Messmethoden, klinische Aussage und Literaturübersicht. J Clin Chem Clin Biochem 1980; 18: 313–26
   PubMedGoogle Scholar
• Wilkin T, Hoskins P J, Armitage M, Rodier M, Casey C, Diaz J-L, Pyke D A, Leslie R DG. Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet 1985; i: 480–2
   Google Scholar
• Heding L G. Determination of total serum insulin (IRI) in insulin treated diabetic patients. Diabetologia 1972; 8: 260–6
   PubMed Web of Science ®Google Scholar
• Kuzuya H, Blix P M, Horwitz D L, Steiner D F, Rubenstein A H. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977; 26: 22–9
   PubMed Web of Science ®Google Scholar
• Hanning I, Home P D, Alberti K GMM. Measurement of ‘free’ insulin: the influence of temperature, storage, and duration of incubation on the desired result. Diabetologia 1985; 28: 831–5
   PubMedGoogle Scholar
• Horwitz D L, Staff J I, Mako M E, Blackard W G, Rubenstein A H. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 1975; 55: 1278–83
   PubMed Web of Science ®Google Scholar
• Liu G, Coulston A, Chen Y-D I, Reaven G M. Does day-long absolute hypoinsu-linemia characterize the patient with non-insulin-dependent diabetes mellitus?. Metabolism 1983; 32: 754–6
   PubMed Web of Science ®Google Scholar
• Ward W K, Beard J C, Halter J B, Pfeifer M A, Porte D. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care 1984; 7: 491–502
   PubMed Web of Science ®Google Scholar
• DeFronzo R A, Ferrannini E. The pathogenesis of non-insulin-dependent diabetes. An update. Medicine 1982; 61: 125–40
   Google Scholar
• Bergman R N, Finegood D T, Ader M. Assessment of insulin sensitivity in vivo. Endocrine Rev 1985; 6: 45–86
   PubMed Web of Science ®Google Scholar
• Hosker J P, Matthews D R, Rudenski A S, Burnett M A, Darling P, Bown E G, Turner R C. Continuous infusion of glucose with model assessment: measurement of insulin resistance and B-cell function in man. Diabetologia 1985; 28: 401–11
   PubMed Web of Science ®Google Scholar
• Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–9
   PubMed Web of Science ®Google Scholar
• Karam J H, Grodsky G M, Forsham P H. Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 1963; 12: 197–204
   PubMed Web of Science ®Google Scholar
• Reaven G M, Moore J, Greenfield M. Quantification of insulin secretion and in vivo insulin action in nonobese and moderately obese individuals with normal glucose tolerance. Diabetes 1983; 32: 600–4
   PubMed Web of Science ®Google Scholar
• Björntorp P, Fahlén M, Grimby G, Gustafson A, Holm J, Renstrom P, Schersten T. Carbohydrate and lipid metabolism in middle-aged, physically well-trained men. Metabolism 1972; 21: 1037–44
   PubMed Web of Science ®Google Scholar
• Lohmann D, Liebold F, Heilmann W, Senger H, Pohl A. Diminished insulin response in highly trained athletes. Metabolism 1978; 27: 521–4
   PubMed Web of Science ®Google Scholar
• Johansen K, Munck O. The relationship between maximal oxygen uptake and glucose tolerance/insulin response ratio in normal young men. Horm Metab Res 1979; 11: 424–7
   Google Scholar
• Berntorp K, Lindgärde F, Malmquist J. High and low insulin responders: relations to oral glucose tolerance, insulin secretion and physical fitness. Acta Med Scand 1984; 216: 111–7
   Google Scholar
• Ducimetiere P, Eschwege E, Papoz L, Richard J L, Claude J R, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19: 205–10
   PubMed Web of Science ®Google Scholar
• Stout R W. The role of insulin in atherosclerosis in diabetics and nondiabetics A review. Diabetes 1981; 30(Suppl. 2)54–7
   Google Scholar
• Polonsky K S, Rubenstein A H. C-peptide as a measure of the secretion and hepatic extraction of insulin Pitfalls and limitations. Diabetes 1984; 33: 486–94
   PubMed Web of Science ®Google Scholar
• Matthews D R, Rudenski A S, Burnett M A, Darling P, Turner R C. The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppression. Clin Endocrinol 1985; 23: 71–9
   Google Scholar
• Jaspan J B, Mako M E, Kuzuya H, Blix P M, Horwitz D L, Rubenstein A H. Abnormalities in circulating beta cell peptides in chronic renal failure: comparison of C-peptide, proinsulin and insulin. J Clin Endocrinol Metab 1977; 45: 441–6
   PubMed Web of Science ®Google Scholar
• Heding L G. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541–8
   PubMed Web of Science ®Google Scholar
• Eaton R P, Allen R C, Schade D S, Erickson K M, Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 1980; 51: 520–8
   PubMed Web of Science ®Google Scholar
• Polonsky K S, Pugh W, Jaspan J B, Cohen D M, Karrison T, Tager H S, Rubenstein A H. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. J Clin Invest 1984; 74: 1821–9
   Google Scholar
• Meistas M T, Margolis S, Kowarski A A. Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am J Physiol 1983; 245: 5455–9
   Google Scholar
• Bonora E, Zavaroni I, Coscelli C, Butturini U. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 1983; 32: 438–46
   PubMed Web of Science ®Google Scholar
• Faber O K, Christensen K, Kehlet H, Madsbad S, Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 1981; 53: 618–21
   PubMed Web of Science ®Google Scholar
• Kolterman O G, Scarlett J A, Olefsky J M. Insulin resistance in non-insulin-dependent, type II diabetes mellitus. Clin Endocrinol Metab 1982; 11: 363–88
   Google Scholar
• Reaven G M. Insulin resistance in non-insulin-dependent diabetes mellitus. Does it exist and can it be measured?. Am J Med 1983; 74(1A)3–17
   Google Scholar
• Reaven G M, Chen Y-D I, Donner C C, Fraze E, Hollenbeck C B. How insulin resistant are patients with non-insulin-dependent diabetes mellitus?. J Clin Endocrinol Metab 1985; 61: 32–6
   Google Scholar
• Efendić S, Luft R, Wajngot A. Aspects of the pathogenesis of type 2 diabetes. Endocrine Rev 1984; 5: 395–410
   PubMedGoogle Scholar
• Bonser A M, Garcia-Webb P. C-peptide measurement and its clinical usefulness: a review. Ann Clin Biochem 1981; 18: 200–6
   Google Scholar
• Madsbad S, Krarup T, McNair P, Christiansen C, Faber O K, Transbøl I, Binder C. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 1981; 210: 153–6
   PubMedGoogle Scholar
• Hoekstra J BL, van Rijn H JM, Thijssen J HH, Erkelens D W. C-peptide reactivity as a measure of insulin dependency in obese diabetic patients treated with insulin. Diabetes Care 1982; 5: 585–91
   PubMed Web of Science ®Google Scholar
• Koskinen P, Viikari J, Irjala K, Kaihola H-L, Seppälä P. C-peptide determination in the choice of treatment in diabetes mellitus. Scand J Clin Lab Invest 1985; 45: 589–597
   PubMed Web of Science ®Google Scholar
• Welborn T A, Garcia-Webb P, Bonser A M. Basal C-peptide in the discrimination of type I from type II diabetes. Diabetes Care 1981; 4: 616–9
   PubMed Web of Science ®Google Scholar
• Garcia-Webb P, Bonser A, Welborn T A. Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus. Diabetologia 1982; 22: 296, (Letter)
   PubMed Web of Science ®Google Scholar
• Rendell M. C-peptide levels as a criterion in treatment of maturity-onset diabetes. J. Clin Endocrinol Metab 1983; 57: 1198–1206
   PubMed Web of Science ®Google Scholar
• Armitage M, Frier B M, Duncan L JP. A misplaced medal? 50 years of unnecessary insulin treatment. Brit Med J 1983; 286: 844
   Google Scholar
• Grant P J, Barlow E, Miles D W. Plasma C-peptide levels identify insulin-treated diabetic patients suitable for oral hypoglycaemic therapy. Diabetic Medicine 1984; 1: 284–6
   Google Scholar
• Cohen M, Crosbie C, Cusworth L, Zimmet P. Insulin—not always a life sentence: withdrawal of insulin therapy in noninsulin dependent diabetes. Diabetes Res 1984; 1: 31–4
   Google Scholar
• Garcia-Webb P, Bonser A, Whiting D. Importance of fasting plasma glucose concentration and obesity in the interpretation of fasting serum C-peptide values. Clin Chim Acta 1982; 118: 323–6
   PubMed Web of Science ®Google Scholar
• Birgerstam G, Malmquist J. Fasting plasma C-peptide levels in health and impaired glucose tolerance: relations to blood glucose and relative body weight. Scand J Clin Lab Invest 1985; 45: 707–12
   PubMed Web of Science ®Google Scholar
• Frank B H, Pettee J M, Zimmerman R E, Burck P J. The production of human pro-insulin and C-peptide. Peptides: Synthesis-Structure-Function. Proceedings of the Seventh American Peptide Symposium, D H Rich, E Gross. Pierce Chemical Company, Rockford, Ill 1981; 729–38
   Google Scholar
• Revers R R, Henry R, Schmeiser L, Kolterman O, Cohen R, Bergenstal R, Polonsky K, Jaspan J, Rubenstein A, Frank B, Galloway J, Olefsky J M. The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes 1984; 33: 762–70
   PubMed Web of Science ®Google Scholar
• Heding L G. Specific and direct radioimmunoassay for human pro-insulin in serum. Diabetologia 1977; 13: 467–74
   Google Scholar
• Rainbow S J, Woodhead J S, Yue D K, Luzio S D, Hales C N. Measurement of human proinsulin by indirect two-site immunoradiometric assay. Diabetologia 1979; 17: 229–34
   Google Scholar
• Cohen R M, Nakabayashi T, Blix P M, Rue P A, Shoelson S E, Root M A, Frank B H, Revers R R, Rubenstein A H. A radioimmunoassay for circulating human proinsulin. Diabetes 1985; 34: 84–91
   Google Scholar
• Deacon C F, Conlon J M. Measurement of circulating human proinsulin concentrations using a proinsulin-specific antiserum. Diabetes 1985; 34: 491–7
   Google Scholar
• Gray I P, Siddle K, Docherty K, Frank B H, Hales C N. Proinsulin in human serum: problems in measurement and interpretation. Clin Endocrinol 1984; 21: 43–7
   Google Scholar
• Heding L G. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics. Diabetes 1978; 27(Suppl. 1)178–83
   Google Scholar
• Turner R C, Heding L G. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 1977; 13: 571–7
   PubMedGoogle Scholar
• Heding L G, Faber O, Kasperska-Czyzykowa T, Sestoft L, Turner R. Radioimmunoassay of proinsulin and hyperpro-insulinemic states. Proinsulin, Insulin, C-peptide, S Baba, T Kaneko, N Yanaihara. Exerpta medica, Amsterdam 1979; 254–61
   Google Scholar
• Gerbitz K-D, Spelsberg F, Bach S, Schumacher I, Boenke B. Pancreatic B-cell peptides as parameters for diagnosis and localisation of hormone secreting tumours. J Clin Chem Clin Biochem 1985; 23: 377–80
   Google Scholar
• Robbins D C, Tager H S, Rubenstein A H. Biological and clinical importance of proinsulin. N Engl J Med 1984; 310: 1165–75
   Google Scholar